Antibody Persistence After a Primary Series of a New DTaP-IPV-Hep B-PRP-T Combined Vaccine or Separate DTaP-IPV//PRP-T and Hepatitis B Vaccines at 2, 4, and 6 Months of Age and the Effect of a Subsequent DTaP-IPV//PRP-T Booster Vaccination at 18 Months of Age in Healthy Argentinean Infants

A DTaP–IPV//PRP∼T vaccine (Pentaxim™): a review of 16 years’ clinical experience

(2011) Stanley A Plotkin et al.   Expert Review of Vaccines

Immunogenicity and safety study of a new DTaP–IPV–Hep B–PRP-T combined vaccine compared to a licensed DTaP–IPV–Hep B//PRP-T comparator, both concomitantly administered with a 7-valent pneumococcal conjugate vaccine at 2, 4, and 6 months of age in Thai infants

(2011) Pope Kosalaraksa et al.   INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES

Immunogenicity and Safety of an Investigational Fully Liquid Hexavalent Combination Vaccine Versus Licensed Combination Vaccines at 6, 10, and 14 Weeks of Age in Healthy South African Infants

(2011) Shabir A. Madhi et al.   PEDIATRIC INFECTIOUS DISEASE JOURNAL

Antibody persistence at 18–20months of age and safety and immunogenicity of a booster dose of a combined DTaP–IPV//PRP∼T vaccine compared to separate vaccines (DTaP, PRP∼T and IPV) following primary vaccination of healthy infants in the People's Republic of China

(2011) Rong Cheng Li et al.   VACCINE

Characterization of the lipid and protein organization in HBsAg viral particles by steady-state and time-resolved fluorescence spectroscopy

(2010) Vanille J. Greiner et al.   BIOCHIMIE

Nanoscale topography of hepatitis B antigen particles by atomic force microscopy

(2010) Pierre-Emmanuel Milhiet et al.   BIOCHIMIE

Correlates of Protection Induced by Vaccination

(2010) S. A. Plotkin   Clinical and Vaccine Immunology

Immunogenicity and safety of a novel yeast Hansenula polymorpha-derived recombinant Hepatitis B candidate vaccine in healthy adolescents and adults aged 10–45 years

(2010) Miguel W. Tregnaghi et al.   VACCINE